Agenda

We'd appreciate your feedback on the event. Please take a few minutes to fill out a survey.

View the agenda below, or download a PDF.

We will also be updating this page with additional event materials. Please check back regularly.

Jump to: Morning breakout sessions | Afternoon breakout sessions

7:30 a.m.  Breakfast and Registration

8:00 a.m.  Welcome and Opening Remarks

  • Elliot Gerson, JD; Executive Vice President, The Aspen Institute
  • Robert Musslewhite, JD; CEO, The Advisory Board Company

8:30 a.m.  Featured Speaker: Update on CMS Innovation Activities

  • Patrick Conway, MD; CMO for the Centers for Medicare and Medicaid Services, Director of the Center for Medicare and Medicaid Innovation, Director of the Center for Clinical Standards and Quality

Download PDF Download presentation

9:30 a.m.  Plenary Session: The New Health Care Market’s Impact on Innovation

The market for health care services is undergoing a rapid transformation as purchasers and consumers face new pressures and incentives. The panel will discuss the ways that innovative providers, payers, suppliers, and others are responding to this new, value-driven market, as well as opportunities for optimizing the market’s incentives.

  • Peter Orszag, PhD, MSc; Vice Chairman of Corporate and Investment Banking, Citigroup
  • Tom Scully, JD; General Partner, Welsh Carson Anderson & Stowe
  • Moderated by: Peter Long, PhD; CEO, Blue Shield of California Foundation

10:15 a.m.  Break

10:30 a.m. Breakout Sessions

Innovation Incubators: Exploring State Approaches to Payment Innovation

Individual states are using their influence as purchasers and regulators of health care to increase the value of care provided to their constituents. This panel will examine the role of states in catalyzing care transformation, testing new payment models, and driving collaboration between stakeholders.

  • Scott Fenn; Chief Integration Officer, Baptist Health System
  • Bruce Goldberg, MD; Director, Oregon Health Authority
  • Craig Jones, MD; Executive Director of Blueprint for Health, Department of Vermont Health Access
  • Jennifer Wood, JD; Chief of Staff and General Counsel, Office of Rhode Island’s Lieutenant Governor Elizabeth Roberts
  • Moderated by: Frederick Isasi, JD; Director, Health Division, National Governors Association Center for Best Practices

How Innovative Employers Are Using Their Purchasing Power to Drive Value

Employers are seeking innovative approaches to slow the growth of health care costs and improve the health of their workforce. This panel will discuss these employer-led innovations, including new models of benefit design, new partnerships with health care providers, and new programs and technology that foster employee wellness.

  • Scott Conard, MD; CMO, Compass Care Engineering
  • Rushika Fernandopulle, MD; Co-founder and CEO, Iora Health
  • David Lansky, PhD; President and CEO, Pacific Business Group on Health
  • Sarah Patterson, MHA; Executive Vice President and Chief Operating Officer, Virginia Mason Medical Center
  • Moderated by: Anton Gunn, President, 937 Strategy Group

Can Fee-for-Service Reward Value? Ways to Adapt Today’s Payment Model

Despite interest in new payment models, many providers likely will continue to be paid through fee-for-service payment systems over the near term. This panel will discuss whether innovations within the fee-for-service paradigm can effectively drive higher-value care, examining both private and public sector efforts to enhance fee-for-service.

  • Chet Burrell; President and CEO, CareFirst BlueCross BlueShield
  • Shannon Fiser; Vice President of Financial Operations, Ardent Health Services
  • Robert Sepucha, JD; Senior Vice President of Policy and Business Development, Fresenius Medical Care
  • Stephen Zuckerman, PhD; Co-Director and Senior Fellow, Health Policy Center, Urban Institute
  • Moderated by: Chas Roades, MBA; Chief Research Officer, The Advisory Board Company

Valuing New Advancements in Care: How Is Value Measured, Who Determines Value, and Why Does It Matter?

Discussion will bring regulators, payers, and providers together to discuss different perceptions of “value”; how future FDA and CMS decision making will encourage biomedical progress; how value considerations will influence the way payers, innovators, and providers measure value; how value-based payment models can reward and stimulate innovation; and the role of personalized medicine in value-based models.

  • Allan Coukell; Senior Director, Drugs and Medical Devices, The Pew Charitable Trusts
  • Jonathan Leff, MBA; Chairman, Deerfield Institute
  • Steven D. Pearson, MD, MSc; President, Institute for Clinical and Economic Review
  • Murray Sheldon, MD; Associate Director of Technology and Innovation at the Center for Devices and Radiological Health, U.S. Food and Drug Administration
  • Moderated by: Steve Usdin; Senior Editor, BioCentury

Accountable Care 2.0: Next Steps in Advancing ACO-Led Innovation

Policymakers and providers alike have begun to wonder what future iterations of accountable care will look like. This panel session will focus on the future path of the accountable care movement, including discussion of community-level accountability, integration of community resources with clinical care, provider approaches to build multi-payer payment models, and efforts to break down competitive concerns in an ACO environment.

  • Karen Ashline; Assistant Vice President, Adirondacks ACO and Northern Adirondack Medical Home
  • Jim Coleman, MBA; Chief Operating Officer, Marshfield Clinic
  • Susan K. Thompson, MS, RN; President and CEO, UnityPoint Health – Fort Dodge
  • Jay Want, MD; CMO, Center for Improving Value in Health Care
  • Moderated by: Kavita Patel, MD; Fellow and Managing Director, Engelberg Center for Health Care Reform, The Brookings Institution

11:45 a.m. Lunch

12:15 p.m. Keynote Address

  • Kathleen Sebelius, Secretary of Health and Human Services

1:00 p.m. Break

1:15 p.m. Plenary Session: The Beltway and Beyond—Understanding the Intersection of Innovation and Public Policy

Legislative and regulatory efforts hold the potential to both accelerate and slow innovative new approaches to health care. Panelists in this session will share perspectives on balancing interests and incentives when addressing important policy questions as well as their expectations on how public policy decisions will impact future innovations.

  • Chris Dawe; Health Policy Advisor, National Economic Council
  • Steve Northrup; Principal, Podesta Group
  • Ashley Ridlon; Senior Manager, Bipartisan Policy Center Advocacy Network
  • Moderated by: Julie Barnes; Senior Advisor, Leavitt Partners

2:15 p.m. Plenary Session: Delivering on Value

To truly transform care, communities and the health care industry must come together to develop effective new approaches to care delivery that protect access, minimize cost, and ensure quality. This plenary session will highlight potential opportunities and lessons learned from ongoing community-based innovations that benefit both individual patients and entire populations.

  • Jeffrey Brenner, MD; Director, Camden Coalition of Healthcare Providers

Download PDF Download presentation

3:00 p.m. Break

3:15 p.m. Breakout Sessions

The Big Data Revolution: Driving Care Improvements Through Data Analysis

Technology innovation and adoption has led to dramatic increases in the number and size of data sets available for improving health care. This panel will discuss ways that “big data”-driven analyses and applications will revolutionize the health care industry’s approach to improving quality and outcomes.

  • Stephan Finn, MD; Director, Office of Analytics and Business Intelligence, Department of Veterans Affairs
  • Claudia Grossmann, PhD; Senior Program Officer, Institute of Medicine
  • David Hanekom, MD; CMO, MDdatacor 
  • Will Shrank, MD; Chief Science Officer and CMO, Provider Innovation and Analytics, CVS Caremark
  • Moderated by: Basit Chaudhry, MD; CEO and Founder, Tuple Health

Innovative Strategies for Getting Information into the Hands of Providers and Patients

As new benefit and payment models transfer risk to patients and providers, both groups need adequate data to enable informed decision making. Panelists in this session will discuss the use of patient- and provider-level data to improve patient engagement, clinical decision making, and allocation of health care resources.

  • Jordan Asher, MD; CMO and Chief Integration Officer, MissionPoint Health Partners
  • Dena Bravata, MD, MS; CMO and Head of Products, Castlight Health
  • Chris Chen, MD; CEO, ChenMed
  • Kevin Larsen, MD; Medical Director of Meaningful Use, Office of the National Coordinator for Health IT
  • Farzad Mostashari, MD; Visiting Fellow of the Engleberg Center for Health Care Reform, The Brookings Institution
  • Moderated by: Aneesh Chopra, MPP; Co-founder and Executive Vice President, Hunch Analytics

Innovative Settings for Care: The Answer to Access, Engagement, and Cost Challenges?

Patients increasingly are placing a premium on access and convenience in choosing care providers. This panel will examine innovative options for providing care in new settings and explore where these shifts in care delivery can address barriers to improving patient health and lowering costs.

  • Krista Drobac, MPP; Executive Director, Alliance for Connected Care and Policy Advisor, DLA Piper
  • Nathan Goldstein; Chief Strategy Officer, Censeo Health
  • A. Michael La Penna, MBA; Principal, The La Penna Group
  • Alan London, MD; Vice President, Strategic Clinical Partnerships, Walgreens Co
  • Moderated by: David Willis, MBA; Vice President of Health System Strategy and Executive Education, The Advisory Board Company

Elevating Patient Engagement to Drive Meaningful Behavior Change

Providers and payers alike need to better engage patients in their care to drive behavior change that yields improvements in health, particularly with regard to chronic disease. The panel will discuss the role of providers and payers in patient engagement, as well as best practices for engaging patients in both treatment and prevention efforts.

  • Lisa Bielamowicz, MD; CMO, The Advisory Board Company
  • Sally Okun, RN; Vice President for Advocacy, Policy and Patient Safety, Patients Like Me
  • Paul Tufano, JD; Executive Vice President, General Counsel, and President of Government Markets, at Independence Blue Cross
  • Moderated by: Patrick Littlefield, PhD; Acting Director, VA Center for Innovation

Bench to Bedside: Translating Discoveries into Treatments

Biomedical science is caught in a paradox: the capacity to make scientific progress is advancing at an unprecedented rate, but research funding is declining and the pressure to reduce health care costs is intensifying. Participants will discuss necessary steps for realizing the promise of science to address critical public health challenges such as Alzheimer’s disease, diabetes, and other
chronic conditions.

  • Ken Davis, MD; President and CEO, Mount Sinai Medical Center
  • Kathy Hudson, PhD; Deputy Director for Science, Outreach, and Policy, National Institutes for Health
  • Louis Jacques, MD; Director, Coverage and Analysis Group, CMS
  • Moderated by: Steve Usdin; Senior Editor, BioCentury

4:30 p.m. Break

4:45 p.m. Plenary Session: Leading the Way—Thoughts on Next Steps for the Innovators of Today and Tomorrow

  • Sen. Thomas Daschle; Senior Fellow at Bipartisan Policy Center
  • Sen. William Frist; Senior Fellow at Bipartisan Policy Center
  • Introduction by: Walter Isaacson; CEO, The Aspen Institute
  • Moderated by: Elliot Gerson, JD; Executive Vice President, The Aspen Institute

5:30 p.m. Closing Remarks

  • Ruth Katz, JD, MPH; Director, Health, Medicine and Society Program, The Aspen Institute
  • Chas Roades, MBA; Chief Research Officer, The Advisory Board Company

For updates on the agenda, follow us on Twitter: #innovatecare14

Made possible by

The Aspen Institute The Advisory Board Company